CIK 0001847367 · <br>Emerging growth company
ALUMIS INC.
Sign in to watch- Ticker
- ALMS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 650-231-6625
- Business address
- 280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- FL2021-001, Inc.
- SC 13D Stake Beneficial Ownership Report
- 4/A Open-market buy Director bought 1,562,500 shares at $16.00 ($25,000,000)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Other events
- SC 13G Stake Amended Statement of Ownership
- SC 13D Stake Beneficial Ownership Report
- 4 Open-market buy 10% owner bought 2,500,000 shares at $16.00 ($40,000,000)
- 4 Open-market buy 10% owner bought 2,500,000 shares at $16.00 ($40,000,000)
- 4 Open-market buy Director bought 2,500,000 shares at $16.00 ($40,000,000)
- SC 13D Stake Beneficial Ownership Report
- 4 Grant or award Director acquired 2,500,000 shares (grant or award)
- 8-K Event Material agreement · Unregistered share sale
- 4 Grant or award Director acquired 23,529 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 1,703,998 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award General Counsel - Corp Secy acquired 33,796 shares (grant or award)
Page 10 of 13 · 249 filings